Baricitinib could open the door to oral treatment for juvenile idiopathic arthritis Presented ByProf. Athimalaipet Ramanan , Bristol Medical School, United Kingdom TrialPhase 3, JUVE-BASIS ConferenceEULAR 2022 TypePeer-reviewed article 21 July 2022 14:22